Australian clinical-stage biotechnology company FivepHusion has announced a commercial transaction with the University of Wollongong for an exclusive option over its ResectAssist Drug Delivery Platform. …
FivepHusion secures ResectAssist platform technology for the localised delivery of cancer drugs
December 11, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
QIMR Berghofer says cell therapy saving lives of immunocompromised patients
December 11, 2024 - - Australian Biotech -
Welcome and encourage these workarounds because they expose the failing institution
December 11, 2024 - - Latest News -
FivepHusion secures ResectAssist platform technology for the localised delivery of cancer drugs
December 11, 2024 - - Latest News -
Budget update will reveal spending and revenue changes, including for the PBS
December 10, 2024 - - Latest News -
Pharmac seeks feedback on funding medicines for liver and ovarian cancer
December 10, 2024 - - Latest News -
Potential Australian developed treatment for MND shows positive early trial results
December 9, 2024 - - Australian Biotech -
TGA approves UCB therapy for the treatment of Dravet syndrome
December 9, 2024 - - Latest News